Challenges surrounding COVID-19 vaccination in Japan: Fraught history and current vaccine hesitancy

(Credit: Unsplash)

This article was exclusively written for The European Sting by Mr. Tai Nguyen Van, a forth-year medical student at the International University of Health and Welfare, Japan. He is affiliated to the International Federation of Medical Students Associations (IFMSA), cordial partner of The Sting. The opinions expressed in this piece belong strictly to the writer and do not necessarily reflect IFMSA’s view on the topic, nor The European Sting’s one.


Japan is facing a third, biggest and most severe wave of COVID-19 and there is yet no signs of abating. COVID-19 vaccine is anticipated as the key strategy to contain the pandemic. However, while millions of people have already been immunized in the United States and European, Japan has not yet approved a single jab.

For a vaccine to get approved in Japan, it requires additional domestic clinical trials to ensure vaccine safety, which means that the process usually takes longer time, and the first vaccine may not be rolled out before late February, the latest among developed countries.

Japan’s current caution in the vaccine approval process has its root in the country’s bitter history when dealing with adverse events following immunizations. In the early 1990s, measles, mumps, and rubella vaccine was suspected to cause aseptic meningitis among children, leading to the vaccine withdrawal in the following years. The government was held liable for adverse reactions related to vaccines, even though there was no definitive link1.

Another event was related to reports of chronic pain and walking abnormalities following human papillomavirus (HPV) vaccine immunization in 2013. Extensive media coverage on the adverse events and public outcry prompted the government to suspend the active recommendation for the shot afterward. However, the problem went on at the court when the anti-vaccine groups established by the parents of “HPV vaccine victims” raised a lawsuit against the government and pharmaceutical company for compensation for the adverse events2.

Those past issues cause the government to be very cautious and passive in introducing new vaccines or taking initiative in vaccination, owing to the fear of being involved in lawsuits.

Vaccine hesitancy may also pose a threat to the COVID-19 vaccination campaign. Japanese’s confidence in vaccines is one of the lowest in the world. Only about eight to nine percent of people strongly agreed that vaccines were safe, according to a Lancet study3. A recent survey by Ipsos found that 31 percent of Japanese said that they did not want the jabs4.

Some medical experts also express doubts about the emergency approval of the vaccine. Dr. Tetsuo Nakayama, the director of the Japanese Society of Clinical Virology, said that despite showing effectiveness in clinical trials, it is uncertain that antibodies created by the vaccine remain a year or two after immunization. There are also concerns related to the vaccines’ long-term safety. The abbreviated development timeline means that there is little opportunity to identify adverse events that might occur in the longer term or only appear after massive administration of the vaccine.

Complacency is another significant factor. Japan’s COVID-19 death toll is about 5000, much smaller in the U.S. and Europe where the death toll has exceeded 500 000. The fact that the risk of developing a severe condition or dying from the disease is low, and most infected people only manifest mild symptoms may, ironically, become a major hurdle to a successful vaccine campaign. 

Reference

  • Gomi, H., & Takahashi, H. (2004). Why is measles still endemic in Japan?. Lancet (London, England), 364(9431), 328–329.
  • Okuhara, T., Ishikawa, H., Okada, M., Kato, M., & Kiuchi, T. (2019). Newspaper coverage before and after the HPV vaccination crisis began in Japan: a text mining analysis. BMC public health, 19(1), 770.
  • de Figueiredo, A., Simas, C., Karafillakis, E., Paterson, P., & Larson, H. J. (2020). Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study. Lancet (London, England)396(10255), 898–908.
  • Ipsos (2020). Global attitude on a Covid-19 vaccine, Ipsos survey for the World Economic Forum. Available at: https://www.ipsos.com/sites/default/files/ct/news/documents/2020-11/global-attitudes-on-a-covid-19-vaccine-oct-2020.pdf. (accessed: January 24th, 2021)

About the author

Tai Nguyen Van is a forth-year medical student at the International University of Health and Welfare, Japan. He is the Director of Academics, AMSA Japan and a student peer reviewer at Journal-AMSA. He has an interest in immunization and vaccine hesitancy. He is the first author of the white paper “The HPV vaccine crisis in Japan”, which were selected as finalist of the academic competition, East Asian Medical Student Conference, Manila 2021.

the sting Milestones

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

EU-Turkey leaders’ meeting, 9 March 2020

Humanitarian aid: EU mobilises over €18 million for the Central African Republic in 2019

COVID-19: MEPs urge quick action to prevent “huge recession”

Climate change is speeding up. Our response needs to be even faster

Here are 10 of the most urgent health challenges we’ll face in the 2020s, according to WHO

Mining the deep seabed will harm biodiversity. We need to talk about it

Syrian crisis: EU mobilises an overall pledge of €6.9 billion for 2020 and beyond

MEPs approve €585 million to support refugees from Syria

How listening to patients could change the way we tackle cancer

Brexit: MEPs concerned over reported UK registration plans for EU27 citizens

Mergers: Commission opens in-depth investigation into proposed acquisition of DSME by HHIH

How banks should prepare for robots going rogue

Yemen: UN Envoy ‘guilty’ of optimistic hope that war is ‘nearing the end’

How to promote Primary Healthcare to the Young Healthcare Workforce?

Youth unemployment: think out of the box

Where does our food come from? Here’s why we need to know

Human rights are ‘key’ for economic policymaking says UN expert

The Dead Sea is drying up, and these two countries have a plan to save it

European Agenda on Migration four years on: Marked progress needs consolidating in face of volatile situation

TTIP wins Merkel’s endorsement ahead of 2016 tough deadline

“Who do I call if I want to call Europe?” Finally a name and a number to answer Henry Kissinger’s question

How a new encryption technique can help protect privacy amid COVID-19

The energy industry is changing. Are governments switched on?

Rapid action needed for people to meet challenges of changing world of work

Scotland in United Kingdom: It’s either the end or the beginning of the end

MEPs approve EU’s spending in 2017

This is the environmental catastrophe you’ve probably never heard of

‘Eden bonds’: how rewilding could save the climate and your pension

Commission statement on the vaccine export authorisation scheme

This is how the coronavirus is affecting indigenous people – and how tech is bringing them together

It takes far too long for a rare disease to be diagnosed. Here’s how that can change

UN chief expresses solidarity with Indonesian authorities after flash floods kill dozens in Papua

Security of 5G networks: EU Member States complete national risk assessments

November infringements package: key decisions

Addressing the consequences of digitalisation in the Russia & CIS region

College meeting: European Commission reorganises the “Task Force for Relations with the United Kingdom” into the “Service for the EU-UK Agreements”.

10 months were not enough for the EU to save the environment but 2 days are

The European Green Deal must be at the heart of the COVID-19 recovery

European Parliament speaks out against “killer robots”

How much time has the ‘European Union of last chance’ left?

Impacting society with digital ingenuity – World Summit Award proclaiming the top 8 worldwide

Here’s a simple and fair way to end corporate tax abuse

Libya: $202 million needed to bring life-saving aid to half a million people hit by humanitarian crisis

Can the EU assume the mantle of global leadership?

COVID has shown we can be creative under pressure: Stockholm’s mayor on harnessing a city’s people power

The future of the plastics industry is green

General Elections in Spain: Twitter organises the first digital debate to empower young people.

UN Human Rights chief urges Venezuela to halt grave rights violations

Medical education and violence against women: a gap in women’s rights

An open letter to Europe’s leaders

Will satellites destroy our view of space?

“Prevention is better than cure”: the main goal of modern medicine

Youth Forum calls on Parliament to ease entry into Europe for young people

Clean air is good for business

Coronavirus: the truth against the myths

Advice on fighting COVID-19 from the Red Cross, a chemist and academics around the world: Today’s coronavirus updates

EU-UK Trade and Cooperation Agreement: protecting European interests, ensuring fair competition, and continued cooperation in areas of mutual interest

How digital can transform healthcare in Asia for millions of people

Managing and resolving conflicts in a politically inclined group of team members

UNICEF reports uneven progress in 30 years of child rights treaty

More Stings?

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s